EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Respiratory adverse effects of IBD treatments: mechanisms, manifestations, and management strategies

Maha E Alsadik, Ahmed A Abdelmoaty, Khaled A Abdel-Sater iD

Canadian Journal of Physiology and Pharmacology · 2026

DOI: 10.1139/cjpp-2026-0151 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Canadian Journal of Physiology and Pharmacology, 2026. Verfasst von Maha E Alsadik und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal and Forensic Medicine, Faculty of Medicine, Mutah University, Al-Karak, Jordan. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Lung Diseases, Immunomodulating Agents. Die Arbeit nennt 59 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Increasing use of immunomodulators and biologics in inflammatory bowel disease (IBD) has expanded the spectrum of pulmonary complications. This review aimed to summarize mechanisms, clinical features, and management of drug-induced pulmonary toxicity in IBD. A narrative review of the PubMed/MEDLINE, Scopus, Embase, and Cochrane Library databases was conducted for studies published between January 2000 and July 2026, using combinations of terms related to inflammatory bowel disease, individual drug classes, and pulmonary toxicity; original studies, systematic reviews, meta-analyses, and case series/reports meeting predefined inclusion criteria were selected by two authors. Each drug class exhibits a characteristic pulmonary toxicity profile, requiring distinct diagnostic and therapeutic approaches. Clinicians must maintain high suspicion for pulmonary toxicity to ensure timely intervention and improved patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Inflammatory Bowel DiseasesLung DiseasesImmunomodulating AgentsHumansAnimalsImmunologic Factors

Stichwörter der Autor:innen

ILDimmunomodulatorsopportunistic infectionspulmonary embolismrespiratory toxicity

Substanzen

Immunomodulating AgentsImmunologic Factors

Autor:innen und Institutionen

  • Department of Internal and Forensic Medicine, Faculty of Medicine, Mutah University, Al-Karak, Jordan.
  • Department of Dental and Medical Sciences, Faculty of Dentistry, Mutah University, Al-Karak, Jordan.

ORCID-Profile: Khaled A Abdel-Sater

Zitieren

APA

Alsadik, M., Abdelmoaty, A., & Abdel-Sater, K. (2026). Respiratory adverse effects of IBD treatments: mechanisms, manifestations, and management strategies. Canadian Journal of Physiology and Pharmacology. https://doi.org/10.1139/cjpp-2026-0151

Vancouver

Alsadik M, Abdelmoaty A, Abdel-Sater K. Respiratory adverse effects of IBD treatments: mechanisms, manifestations, and management strategies. Canadian Journal of Physiology and Pharmacology. 2026. doi:10.1139/cjpp-2026-0151

BibTeX
@article{Alsadik2026,
  author = {Alsadik, Maha E and Abdelmoaty, Ahmed A and Abdel-Sater, Khaled A},
  title = {Respiratory adverse effects of IBD treatments: mechanisms, manifestations, and management strategies},
  journal = {Canadian Journal of Physiology and Pharmacology},
  year = {2026},
  doi = {10.1139/cjpp-2026-0151}
}
Kostenlos starten →